Ліки для людей, або новий Закон про лікарські засоби

Proof of Concept (PoC) successfully provides primary packaging with a unique ID to access its own trustworthy digital twin Users gain immediate access to quality and process data of products…

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…